NCT00295607View on ClinicalTrials.gov

Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Hepatitis CLiver Transplantation
Interventions
DRUG

Tacrolimus

immunosuppression

DRUG

steroids, monoclonal anti-IL2R antibody

immunosuppression

Trial Locations (17)

13353

Berlin

15706

Santiago

16132

Genova

20251

Hamburg

25030

Besançon

28035

Madrid

41100

Modena

48903

Barakaldo

55131

Mainz

69317

Lyon

94804

Villejuif

140 21

Prague

06202

Nice

Unknown

Bologna

02-097

Warsaw

413 45

Gothenburg

SE5 9RS

London

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY